The University of Chicago Header Logo

Type II endometrial cancers with minimal, non-invasive residual disease on final pathology: What should we do next?

Type II endometrial cancers with minimal, non-invasive residual disease on final pathology: What should we do next? Gynecol Oncol Rep. 2019 Aug; 29:20-24.

View in: PubMed